Corporate Overview & Strategy
Univerasal Biosensors (UBI) is a medical diagnostics company focused on the research, development and manufacture of diagnostic test systems for point-of-care (POC) professional and home use. UBI has developed a blood glucose monitoring product that is being commercialised globally by LifeScan, Inc. a Johnson & Johnson company.
UBI's innovative electrochemical sensor platform in also being applied to develop a range of other medical and healthcare applications.
The company is listed on the Australian Securities Exchange under the ticker "UBI", and operates from its manufacturing and R&D facility in Melbourne, Australia.
UBI's core strategy is to:
- Support LifeScan in the development, manufacture and post-market support of the One Touch Verio blood glucose product
- Extend the electrochemical technology platform to a range of other point of care tests
- To develop strategic partnerships with industry leaders to market and distribute UBI's technology.
Read more about Corporate Overiew & Strategy